Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Avivagen Inc V.VIV

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Major
Alternate Symbol(s):  CHEXF

Avivagen Inc is a development-stage biotechnology company. The Company develops science-based, natural health products for animals that are proven in clinical trials and offering veterinarians real alternatives to traditional treatments.
Price: $0.065 | Change: +$0.005 | %Change: +8.33%
Volume: 603,173 | Day High/Low: 0.065/0.065 | 52 Week High/Low: 0.10/0.055
View modes: 
0 stars

RE:RE:McDonld's to use chicken without antibiotics used for humans

The long wait will be for Ocx Beta to be allowed for use and sale in North America.  Based on the interview we would need proof of sales to fund a more testing in Canada and the US for more
0 stars

Huffington Post article on McDonald's not using antibiotics  rate and reply
0 stars

RE:McDonld's to use chicken without antibiotics used for humans

As well as A & W ...  rate and reply
0 stars

McDonld's to use chicken without antibiotics used for humans

It's coming.......  rate and reply
0 stars

RE:Interview released today

I just added your post on twitter... VIV is gaining momentum today, I wouldn't be surprised if 6 was our bottom. a wait and see  rate and reply
0 stars

nice write up

Gives us some confidence that this may move this year. I added a lot more today and am now fully committed with a little powder left. gl  rate and reply
5 stars

Interview released today

AVIVAGEN INTERVIEW – CEO Cameron Groome What happens when you formulate a great idea with massive potential but decide the method of implementation needs re-working? Many tech ventures abound more
0 stars


Thought so!  But I win; I first bought north of $0.22 and actually particapated in an offering at $0.20 (including warrants with a strike of $0.20 which expired in October).  However, i DO share more
0 stars

RE:stock price

Haha - thanks Birchy! I've been around a long time - bought in at .13 - so that will tell you when. Have accumulated 300K+ - but I honestly thought we would have started to appreciate value with more
0 stars

stock price

sjaplo: The answer to your first question:   EASY; it's been reading your post. Actaully, in all seriousness, we ALL are frustrated with this stock's performance.  However, we are (I more
0 stars

RE:RE:Poultry results are out

Ok two things....... 1. How do you tell if a chicken is depressed 2. "Moribund specimens should be removed due to cannabalism........" Wow. You know I'm becoming quite disenchanted with this more
5 stars

RE:Poultry results are out

we are now included in prevention of Necrotic enteritis Necrotic enteritis is an acute enterotoxemia. The clinical illness is usually very short, and often the only signs are a severe more
0 stars

Poultry results are out

Avivagen Summarizes Final Poultry Trial Results   (via   Ottawa, ON / TheNewswire / Mar 3 2015 / - Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness more
0 stars


Avivagen Summarizes Final Poultry Trial Results Mar 03, 2015 Ottawa, ON / TNW-Accesswire / Mar 3 2015 / – Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a wellness company developing more
0 stars

Above average volume today

action (new vol)  seem to be going on.. on VIV today on other Trading Sysytem ... V:VIV - AVIVAGEN INC - 10:20:22 EST Sym-X Bid - Ask Last Chg %Ch Vol $Vol more
1 star


Birchview..I'm glad you are psyched about 2015. I would be in that group (psyched) if we could at least move our sp base up a couple of cents. The setback in the non-surgical sterilization process more
3 stars


I don't think there is much value to "unleash" with the pet supplements, makingmoneynow, no matter how good the supplements are. I think that the market for these supplements is very small more
3 stars

Two years

Coming up on two years since Cameron Groome(sic) took the reins of Avivagen. I recall his introductive remarks stating he was intent on increasing shareholder value. Since that time he has stated more
0 stars


I agree with you Brich, Bayer slept on an order for months and never sold it. So, it is in the best interests of Avivagen and its shareholders just to terminate the contract and move on. In more
5 stars


Very good point Freedom.  It sounds moot, but huge corporations like Bayer never really like inheriting "contracts" the terms of which were negotiated by someone else.  Each company has their more